Navigation Links
Osseon Launches in Europe
Date:2/16/2010

SANTA ROSA, Calif., Feb. 16 /PRNewswire/ -- Osseon Therapeutics Inc. today announced it has completed its first Osseoplasty™ procedures in Europe. The procedures were performed in Milan, Italy.

Teaming with its European distributor MBA Incorporado, SL, the largest independent medical device distributor in Europe, Osseoplasty cases are also scheduled to begin in the next weeks in the United Kingdom, Germany and Spain.

Osseon's product line features the Osseoflex™ (steerable and curvable needle) and Osseoperm™ (bone cement). These products combine to form a unique new procedure termed Osseoplasty to treat painful acute fractures of the vertebrae seen increasingly in older individuals with osteoporosis and osteometastatic injuries.

Osseoflex can access the entire vertebral body from a singular unipedicular percutaneous access point. The Osseoplasty system is unique for its delivery of optimal viscosity cement and precise cement placement through the highly maneuverable Osseoflex needle. The Osseoplasty procedure provides rapid stabilization of vertebral fractures and significant pain relief on the day of treatment.

MBA will distribute Osseon's products to physicians and hospitals throughout the European Union, including the United Kingdom, Germany, Spain, Portugal, Italy, Greece, Austria, Switzerland, Scandinavia, Turkey and Germany.

According to John Stalcup, Ph.D., CEO of Osseon, "MBA has an excellent and long-established international reputation for marketing and distributing medical devices for independent innovators and an unparalleled reputation for customer service. The partnership between MBA and Osseon represents a major step forward in the expansion of Osseoplasty into the key markets of Europe."

Osseon website:  http://www.osseon.com

SOURCE Osseon Therapeutics, Inc.

RELATED LINKS
http://www.osseon.com

'/>"/>

SOURCE Osseon Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. IntegriChain Launches DNA: Dynamic NextGen Analytics(TM) Platform
2. BD Launches New Device Designed to Improve Safety, Accuracy and Turnaround Time of Blood Collection in Patients with Fragile Veins
3. Centerphase Solutions, Inc. Launches New Clinical Trials Business Model Company
4. BD Launches Be a Flu Fighter Campaign to Promote Influenza Awareness and Prevention in Schools, Hospitals and Laboratories
5. Elekta Launches New Web Site for Global Health Care Community
6. Healthpoint Launches Collagenase SANTYL(R) Ointment in Canada
7. BioCrysts Partner Shionogi Launches Peramivir In Japan Under The Name RAPIACTA
8. American Imaging Management Launches New Patient Safety Program Podcasts
9. VisEn Launches New Cat B 680 FAST(TM) Fluorescence Molecular Imaging Agent
10. Sagent Pharmaceuticals Launches Pamidronate Disodium Injection
11. ARKRAY, Inc. Long Term Care Division Launches Comprehensive Service Program - Assure(R) Brilliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... 2017 Companion animal ... in pets such as canine, avian and feline. ... types such as Attenuated Live Vaccines, Conjugate Vaccines, ... and Recombinant Vaccines. Attenuated live vaccines are derived ... which have been weakend under laboratory conditions. Conjugate ...
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group leased ... is developing at Conejo Spectrum Business Park in ... Atara Biotherapeutics, Inc. , a biopharmaceutical company ... life-threatening diseases that have been underserved by scientific ... therapies for cancer, autoimmune and infectious disease. ...
(Date:4/18/2017)... , April 18, 2017 Viverae ® , ... announce the integration of IBM ® Watson Campaign ... deliver targeted communications for a personalized experience. Through digital ... on their health in real time. The enhanced experience ... most to members, wherever they are in their journey ...
Breaking Medicine Technology:
(Date:4/25/2017)... (PRWEB) , ... April 25, ... ... based in Newport Beach, California, committed to raising awareness for Duchenne muscular ... results from its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial ...
(Date:4/25/2017)... ... April 25, 2017 , ... As President Trump challenges ... for how his administration could impact the employee benefits industry. James Slotnick, AVP, ... most likely to make it through Congress. His discussion will focus on the ...
(Date:4/25/2017)... ... April 25, 2017 , ... The doctors at Wall Centre Dental ... with dental fear and require sedation to receive dental care. The doctors offer three ... procedures, from hygienic cleanings to oral surgery, at their dental office in Vancouver. Wall ...
(Date:4/25/2017)... ... April 25, 2017 , ... Patients who would like ... in a fraction of the time as traditional braces – Wilckodontics®. Dr. Victoria ... now offers this revolutionary treatment with or without a referral. , Wilckodontics ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... in unveiling cutting-edge birth defects research related to Zika virus during pregnancy, as ... premier society for this important science. , The Teratology Society ...
Breaking Medicine News(10 mins):